ERN1 and neoplasm: Here, we took advantage of the selective signaling properties of different IRE1 GBM somatic mutants and we demonstrate that the modulation of IRE1 signaling characteristics in GBM cells controls tumor aggressiveness, not only by providing selective advantages to the tumor cells themselves, but also by remodeling the tumor stroma to the benefit of growth.